A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer

Breast Cancer Research and Treatment

Volumn 118, Issue 1, 2009, Pages 207-211

  Bogdanova, Natalia ^a   Cybulski, Cezary ^b   Bermisheva, Marina ^c   Datsyuk, Ihor ^d   Yamini, Paria ^a   Hillemanns, Peter ^a   Antonenkova, Natalja Nikolaevna ^e   Khusnutdinova, Elza ^c   Lubinski, Jan ^b   Dörk, Thilo ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c INSTITUTE OF BIOCHEMISTRY AND GENETICS   (Russian Federation)

^d R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^e Research Institute of Oncology and Medical Radiology of the Ministry of Health of the Byelorussian SSR   (Belarus)

Author keywords

Ataxia telangiectasia; ATM; Breast cancer genetics; Radiosensitivity; Slavic founder mutation

Indexed keywords

ADULT; ARTICLE; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; NONSENSE MUTATION; POLAND; PRIORITY JOURNAL; RUSSIAN FEDERATION;

ADULT; BREAST NEOPLASMS; BYELARUS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CODON, NONSENSE; DNA-BINDING PROTEINS; FAMILY HEALTH; FEMALE; FOUNDER EFFECT; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; ODDS RATIO; POINT MUTATION; POLAND; PROTEIN-SERINE-THREONINE KINASES; RUSSIA; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEINS; UKRAINE;

EID: 70349912565     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0189-9     Document Type: Article

References (28)

1. Gatti RA (2002) Ataxia-telangiectasia. In: Vogelstein B, Kinzler KW (eds) The genetic basis of human cancer. McGraw-Hill, New York, pp 239-266
2. Y Shiloh 2003 ATM and related protein kinases: safeguarding genome integrity Nat Rev Cancer 3 3 155 168 10.1038/nrc1011 10.1038/nrc1011 1:CAS:528:DC%2BD3sXhsFGhtr4%3D 12612651 (Pubitemid 37328868)
3. M Swift L Sholman M Perry C Chase 1976 Malignant neoplasms in the families of patients with ataxia-telangiectasia Cancer Res 36 1 209 215 1:STN:280:DyaE287hs1Whtw%3D%3D 1248000
4. M Swift PJ Reitnauer D Morrell CL Chase 1987 Breast and other cancers in families with ataxia-telangiectasia N Engl J Med 316 21 1289 1294 1:STN:280:DyaL2s3gtFOltQ%3D%3D 3574400
5. M Swift D Morrell RB Massey CL Chase 1991 Incidence of cancer in 161 families affected by ataxia-telangiectasia N Engl J Med 325 26 1831 1836 1:STN:280:DyaK38%2Fnt1KgsA%3D%3D 1961222
6. P Athma R Rappaport M Swift 1996 Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer Cancer Genet Cytogenet 92 2 130 134 10.1016/S0165-4608(96)00328-7 10.1016/S0165- 4608(96)00328-7 1:STN:280:DyaK2s7jtVKjtA%3D%3D 8976369 (Pubitemid 26427675)
7. HM Inskip LJ Kinlen AM Taylor CG Woods CF Arlett 1999 Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia Br J Cancer 79 7-8 1304 1307 10.1038/sj.bjc.6690209 10.1038/sj.bjc.6690209 1:STN:280:DyaK1M7ps1CisA%3D%3D 10098776 (Pubitemid 29087915)
8. D Thompson S Duedal J Kirner, et al. 2005 Cancer risks and mortality in heterozygous ATM mutation carriers J Natl Cancer Inst 97 11 813 822 1:CAS:528:DC%2BD2MXkvVShtbc%3D 15928302
9. JH Olsen JM Hahnemann AL Børresen-Dale, et al. 2005 Breast and other cancers in 1,445 blood relatives of 75 Nordic patients with ataxia-telangiectasia Br J Cancer 93 2 260 265 10.1038/sj.bjc.6602658 10.1038/sj.bjc.6602658 1:STN:280:DC%2BD2MzntFyntw%3D%3D 15942625 (Pubitemid 41133213)
10. E Cavaciuti A Laugé N Janin K Ossian J Hall D Stoppa-Lyonnet, et al. 2005 Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families Genes Chromosom Cancer 42 1 1 9 10.1002/gcc.20101 10.1002/gcc.20101 1:CAS:528:DC%2BD2cXhtFGmsrfM 15390180 (Pubitemid 39578660)
11. MG FitzGerald JM Bean SR Hegde, et al. 1997 Heterozygous ATM mutations do not contribute to early onset of breast cancer Nat Genet 15 3 307 310 10.1038/ng0397-307 10.1038/ng0397-307 1:CAS:528:DyaK2sXhsVGqs7s%3D 9054948 (Pubitemid 27098729)
12. A Broeks JH Urbanus AN Floore, et al. 2000 ATM-heterozygous germline mutations contribute to breast cancer-susceptibility Am J Hum Genet 66 2 494 500 10.1086/302746 10.1086/302746 1:CAS:528:DC%2BD3cXitFyit74%3D 10677309 (Pubitemid 30468827)
13. T Dörk R Bendix M Bremer, et al. 2001 Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients Cancer Res 61 20 7608 7615 11606401
14. YR Thorstenson A Roxas R Kroiss, et al. 2003 Contributions of ATM mutations to familial breast and ovarian cancer Cancer Res 63 12 3325 3333 1:CAS:528:DC%2BD3sXks1ehsr0%3D 12810666
15. CI Szabo M Schutte A Broeks, et al. 2004 Are ATM mutations 7271T→G and IVS10-6T→G really high-risk breast cancer-susceptibility alleles? Cancer Res 64 3 840 843 10.1158/0008-5472.CAN-03-2678 10.1158/0008-5472.CAN-03- 2678 1:CAS:528:DC%2BD2cXhtFCgtLg%3D 14871810 (Pubitemid 38176882)
16. J Tommiska L Jansen O Kilpivaara, et al. 2006 ATM variants and cancer risk in breast cancer patients from Southern Finland BMC Cancer 6 209 10.1186/1471-2407-6-209 10.1186/1471-2407-6-209 16914028 (Pubitemid 44530032)
17. J Brunet S Gutiérrez-Enríquez A Torres, et al. 2008 ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations Clin Genet 73 5 465 473 10.1111/j.1399-0004.2008.00987.x 1:STN:280:DC%2BD1c3jvFyqsA%3D%3D 18384426
18. A Renwick D Thompson S Seal, et al. 2006 ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles Nat Genet 38 8 873 875 10.1038/ng1837 10.1038/ng1837 1:CAS:528:DC%2BD28XnsVChu7Y%3D 16832357 (Pubitemid 44141653)
19. M Telatar S Teraoka Z Wang, et al. 1998 Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations Am J Hum Genet 62 1 86 97 10.1086/301673 10.1086/301673 1:CAS:528:DyaK1cXhsVGrsrw%3D 9443866 (Pubitemid 28093838)
20. N Sandoval M Platzer A Rosenthal, et al. 1999 Characterization of ATM gene mutations in 66 ataxia-telangiectasia families Hum Mol Genet 8 69 79 10.1093/hmg/8.1.69 10.1093/hmg/8.1.69 1:CAS:528:DyaK1MXosleqtw%3D%3D 9887333 (Pubitemid 29039050)
21. GW Birrell K Kneebone M Nefedov E Nefedova MN Jartsev M Mitsui, et al. 2005 ATM mutations, haplotype analysis, and immunological status of Russian patients with ataxia-telangiectasia Hum Mutat 25 6 593 10.1002/humu.9341 10.1002/humu.9341 15880721
22. CHEK2 Breast Cancer Case Control Consortium 2004 CHEK2 1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies Am J Hum Genet 74 6 1175 1182 10.1086/421251 10.1086/421251 (Pubitemid 38669316)
23. B Górski C Cybulski T Huzarski, et al. 2005 Breast cancer predisposing alleles in Poland Breast Cancer Res Treat 92 1 19 24 10.1007/s10549-005-1409-1 10.1007/s10549-005-1409-1 15980987 (Pubitemid 40875074)
24. K Heikkinen K Rapakko SM Karppinen, et al. 2006 RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability Carcinogenesis 27 8 1593 1599 10.1093/carcin/bgi360 10.1093/carcin/bgi360 1:CAS:528: DC%2BD28XosVemu78%3D 16474176 (Pubitemid 44288048)
25. H Erkko B Xia J Nikkilä, et al. 2007 A recurrent mutation in PALB2 in Finnish cancer families Nature 446 7133 316 319 10.1038/nature05609 10.1038/nature05609 1:CAS:528:DC%2BD2sXivVSns78%3D 17287723 (Pubitemid 46426155)
26. N Bogdanova S Feshchenko P Schürmann, et al. 2008 Nijmegen breakage syndrome mutations and risk of breast cancer Int J Cancer 122 4 802 806 10.1002/ijc.23168 10.1002/ijc.23168 1:CAS:528:DC%2BD1cXhsFShs7w%3D 17957789
27. K Pylkäs J Tommiska K Syrjäkoski, et al. 2007 Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer Carcinogenesis 28 5 1040 1045 10.1093/carcin/bgl237 10.1093/carcin/bgl237 17166884 (Pubitemid 47072188)
28. JL Bernstein S Teraoka MC Southey, et al. 2006 Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry Hum Mutat 27 11 1122 1128 10.1002/humu.20415 10.1002/humu.20415 1:CAS:528: DC%2BD28Xht1GktLfL 16958054 (Pubitemid 44730507)